Glossary
Acronym | Definition | ||
---|---|---|---|
AMR | Antimicrobial Resistance | ||
ARV | Antiretroviral | ||
BARDA | Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services |
||
CDC | Centers for Disease Control and Prevention | ||
EH&S | Environmental Health and Safety | ||
EMA | European Medicines Agency | ||
ESG | Environmental, Social and Governance | ||
EUA | Emergency Use Authorization | ||
FDA | U.S. Food and Drug Administration | ||
GPH | Global Public Health | ||
JJBC | Johnson & Johnson Bioethics Committee | ||
JJMDC | Johnson & Johnson Medical Devices Companies | ||
JLABS | Johnson & Johnson Innovation—JLABS | ||
LMICs | Low- and middle-income countries | ||
MDR-TB | Multidrug-resistant tuberculosis | ||
OCMO | The Johnson & Johnson Office of the Chief Medical Officer | ||
OCMS | Office of Consumer Medical Safety | ||
PTA | Priority Topics Assessment | ||
RSV | Respiratory syncytial virus | ||
RWD | Real-world data | ||
RWE | Real-world evidence | ||
SDG | Sustainable Development Goal (of the United Nations) | ||
STH | Soil Transmitted Helminths (or intestinal parasites) | ||
USAID | U.S. Agency for International Development | ||
WHO | World Health Organization |